These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 11866215)

  • 1. Omission of Chemotherapy for the Treatment of Mucinous Breast Cancer: A Nationwide Study from the Korean Breast Cancer Society.
    Kim HS; Lee JU; Yoo TK; Chae BJ; Son D; Kim YJ; Park WC
    J Breast Cancer; 2019 Dec; 22(4):599-612. PubMed ID: 31897333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction to: Angiogenesis: Methods and Protocols.
    Benest AV
    Methods Mol Biol; 2022; 2441():C1. PubMed ID: 35435601
    [No Abstract]   [Full Text] [Related]  

  • 3. BCL-2, topoisomerase IIα, microvessel density and prognosis of early advanced breast cancer patients after adjuvant anthracycline-based chemotherapy.
    Biesaga B; Niemiec J; Ziobro M
    J Cancer Res Clin Oncol; 2014 Dec; 140(12):2009-19. PubMed ID: 25005788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microvessel density and status of p53 protein as potential prognostic factors for adjuvant anthracycline chemotherapy in retrospective analysis of early breast cancer patients group.
    Biesaga B; Niemiec J; Ziobro M
    Pathol Oncol Res; 2012 Oct; 18(4):949-60. PubMed ID: 22549273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor angiogenesis predicts clinical outcome of node-positive breast cancer patients treated with adjuvant hormone therapy or chemotherapy.
    Gasparini G; Barbareschi M; Boracchi P; Verderio P; Caffo O; Meli S; Dalla Palma P; Marubini E; Bevilacqua P
    Cancer J Sci Am; 1995; 1(2):131-41. PubMed ID: 9166466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying good prognosis group of breast cancer patients with 1-3 positive axillary nodes for adjuvant cyclophosphamide, methotrexate and 5-fluorouracil (CMF) chemotherapy.
    Lin YC; Chen SC; Chang HK; Hsueh S; Tsai CS; Lo YF; Hwang TL; Chen MF
    Jpn J Clin Oncol; 2005 Sep; 35(9):514-9. PubMed ID: 16199422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy.
    Gasparini G; Toi M; Miceli R; Vermeulen PB; Dittadi R; Biganzoli E; Morabito A; Fanelli M; Gatti C; Suzuki H; Tominaga T; Dirix LY; Gion M
    Cancer J Sci Am; 1999; 5(2):101-11. PubMed ID: 10198732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.
    Gasparini G; Barbareschi M; Doglioni C; Palma PD; Mauri FA; Boracchi P; Bevilacqua P; Caffo O; Morelli L; Verderio P
    Clin Cancer Res; 1995 Feb; 1(2):189-98. PubMed ID: 9815973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic importance of tumor angiogenesis in breast carcinoma with adjuvant chemotherapy.
    Gunel N; Akcali Z; Coskun U; Akyol G; Yamac D; Yenidünya S
    Pathol Res Pract; 2002; 198(1):7-12. PubMed ID: 11866215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of intratumoral vascularization (angiogenesis) in breast cancer prognosis.
    Heimann R; Ferguson D; Gray S; Hellman S
    Breast Cancer Res Treat; 1998; 52(1-3):147-58. PubMed ID: 10066079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool.
    Gasparini G; Harris AL
    J Clin Oncol; 1995 Mar; 13(3):765-82. PubMed ID: 7533829
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.